References
1. Li X, Xu S, Yu M, et al. Risk
factors for severity and mortality in adult COVID-19 inpatients in
Wuhan. J Allergy Clin Immunol 2020;146:110-118.
2. Richardson S, Hirsch JS, Narasimhan
M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among
5700 Patients Hospitalized With COVID-19 in the New York City Area. Jama
2020;323:2052-2059.
3. Zhu Z, Hasegawa K, Ma B, Fujiogi M,
Camargo CA, Jr., Liang L. Association of asthma and its genetic
predisposition with the risk of severe COVID-19. J Allergy Clin Immunol
2020;146:327-9 e4.
4. Williamson EJ, Walker AJ, Bhaskaran
K, et al. Factors associated with COVID-19-related death using
OpenSAFELY. Nature 2020;584:430-436.
5. Chhiba KD, Patel GB, Vu THT, et al.
Prevalence and characterization of asthma in hospitalized and
nonhospitalized patients with COVID-19. J Allergy Clin Immunol
2020;146:307-314.e4.
6. Sung HK, Kim JY, Heo J, et al.
Clinical Course and Outcomes of 3,060 Patients with Coronavirus Disease
2019 in Korea, January-May 2020. J Korean Med Sci 2020;35:e280.
Table 1 General characteristics of the participants with
COVID-19 according to asthma history